TABLE 1.

LT IgG GMT for subjects immunized transcutaneously

Study dayGMT (EU)
Group 1 (n = 20)Group 2 (n = 20)Group 3 (n = 20)All treatments (n = 60)
0369656a514499
215,2178,5535,5956,297
4212,73412,98810,93912,185
9010,77214,35011,22212,016
  • a P = 0.008 for a pairwise comparison of group 1 and group 2 using the covariate-adjusted and unadjusted generalized linear model.